These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

138 related articles for article (PubMed ID: 2892507)

  • 21. Seroprevalence of IgG antibodies against Bordetella pertussis in healthy individuals aged 4-24 years in Turkey.
    Cevik M; Beyazova U; Aral AL; Duyan Camurdan A; Ozkan S; Sahin F; Aybay C
    Clin Microbiol Infect; 2008 Apr; 14(4):388-90. PubMed ID: 18190581
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Kinetics and sensitivity of ELISA IgG pertussis antitoxin after infection and vaccination with Bordetella pertussis in young children.
    Hallander HO; Ljungman M; Storsaeter J; Gustafsson L
    APMIS; 2009 Nov; 117(11):797-807. PubMed ID: 19845530
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The cellular immune response to Bordetella pertussis in two children with whooping cough.
    Hafler JP; Pohl-Koppe A
    Eur J Med Res; 1998 Nov; 3(11):523-6. PubMed ID: 9810032
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Anti-pertussis toxin IgG and anti-filamentous hemagglutinin IgG production in children immunized with pertussis acellular vaccine and comparison of these titers with the sera of pertussis convalescent children.
    Sato Y; Sato H
    Dev Biol Stand; 1985; 61():367-72. PubMed ID: 3835079
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A nasal whole-cell pertussis vaccine induces specific systemic and cross-reactive mucosal antibody responses in human volunteers.
    Berstad AKH; Holst J; Frøholm LO; Haugen IL; Wedege E; Oftung F; Haneberg B
    J Med Microbiol; 2000 Feb; 49(2):157-163. PubMed ID: 10670566
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Expression of a pertussis toxin S1 fragment by inducible promoters in oral Streptococcus and the induction of immune responses during oral colonization in mice.
    Mallaley PP; Halperin SA; Morris A; MacMillan A; Lee SF
    Can J Microbiol; 2006 May; 52(5):436-44. PubMed ID: 16699568
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bordetella pertussis isolates in Finland: serotype and fimbrial expression.
    Heikkinen E; Xing DK; Olander RM; Hytönen J; Viljanen MK; Mertsola J; He Q
    BMC Microbiol; 2008 Sep; 8():162. PubMed ID: 18816412
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Immunogenicity of acellular pertussis vaccines.
    Hallander H; Reizenstein E
    Biologicals; 1994 Dec; 22(4):391-5. PubMed ID: 7779367
    [No Abstract]   [Full Text] [Related]  

  • 29. Cellular immunity in adolescents and adults following acellular pertussis vaccine administration.
    Meyer CU; Zepp F; Decker M; Lee M; Chang SJ; Ward J; Yoder S; Bogaert H; Edwards KM
    Clin Vaccine Immunol; 2007 Mar; 14(3):288-92. PubMed ID: 17267589
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Components of acellular pertussis vaccines.
    Preston NW; Matthews RC
    Lancet; 1996 Mar; 347(9003):764. PubMed ID: 8602023
    [No Abstract]   [Full Text] [Related]  

  • 31. Immunological surveys of antibodies against B. pertussis and B. parapertussis in some African and Asian countries.
    Maixnerova M; Buriánová B; Teplý V; Pecenka J; Serý V; Jezek Z
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(2):201-11. PubMed ID: 231624
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Prevalence of antibody to Bordetella pertussis antigens in serum specimens obtained from 1793 adolescents and adults.
    Cherry JD; Chang SJ; Klein D; Lee M; Barenkamp S; Bernstein D; Edelman R; Decker MD; Greenberg DP; Keitel W; Treanor J; Ward JI
    Clin Infect Dis; 2004 Dec; 39(11):1715-8. PubMed ID: 15578376
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Development and clinical use of an oral heat-inactivated whole cell pertussis vaccine.
    Baumann E; Binder BR; Falk W; Huber EG; Kurz R; Rosanelli K
    Dev Biol Stand; 1985; 61():511-6. PubMed ID: 2872129
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Mouse and pig models for studies of natural and vaccine-induced immunity to Bordetella pertussis.
    Mills KH; Gerdts V
    J Infect Dis; 2014 Apr; 209 Suppl 1():S16-9. PubMed ID: 24626866
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Poly(lactide-co-glycolide) microencapsulation of vaccine antigens.
    Jones DH; McBride BW; Farrar GH
    J Biotechnol; 1996 Jan; 44(1-3):29-36. PubMed ID: 8717383
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Cytokine and antibody profiles in 1-year-old children vaccinated with either acellular or whole-cell pertussis vaccine during infancy.
    Dirix V; Verscheure V; Goetghebuer T; Hainaut M; Debrie AS; Locht C; Mascart F
    Vaccine; 2009 Oct; 27(43):6042-7. PubMed ID: 19665604
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Diagnostic image (136). A boy with coughing fits and subconjunctival hemorrhage. Subconjunctival hemorrhage secondary to whooping cough].
    op de Coul ME; Budde JH
    Ned Tijdschr Geneeskd; 2003 Apr; 147(17):805. PubMed ID: 12741169
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The benefits of using diverse animal models for studying pertussis.
    Elahi S; Holmstrom J; Gerdts V
    Trends Microbiol; 2007 Oct; 15(10):462-8. PubMed ID: 17920273
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Serum IgG antibody responses to pertussis toxin and filamentous hemagglutinin in nonvaccinated and vaccinated children and adults with pertussis.
    Trollfors B; Taranger J; Lagergård T; Sundh V; Bryla DA; Schneerson R; Robbins JB
    Clin Infect Dis; 1999 Mar; 28(3):552-9. PubMed ID: 10194077
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bordetella parapertussis infections.
    Mastrantonio P; Giuliano M; Stefanelli P; Sofia T; De Marzi L; Tarabini G; Quarto M; Moiraghi A
    Dev Biol Stand; 1997; 89():255-9. PubMed ID: 9272358
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 7.